One Dose of Antibody Injection can Prevent Peanut Allergy for 6 Weeks
Severe peanut allergy can be prevented for 2 to 6 weeks with one dose of antibody injection called etokimab.
Severe peanut allergy can be prevented for 2 to 6 weeks with one dose of antibody injection called etokimab.
‘Peanuts are among the most common food allergies, affecting an estimated 1.6 million kids in the United States.
’
Read More..Tweet it Now
“The patients I treated have universally expressed relief that they no longer have to live in constant fear that one wrong bite of something with peanuts will result in an emergency injection of epinephrine,” said Christina Ciaccio, MD, MSc, UChicago Medicine associate professor of pediatrics and medicine and the site’s principal investigator. Read More..
Ciaccio administered the treatment as part of a 2018 clinical trial funded by Aimmune Therapeutics. During the trial, patients at sites, including at UChicago Medicine Comer Children’s Hospital, received the treatment. The research was conducted in 10 countries across North America and Europe.
“I cannot emphasize enough what a game-changer it will be for both food allergy practitioners and patients to have an FDA-approved product to treat peanut allergy effectively,” Ciaccio said. “To date, we have not been able to do anything but tell patients to monitor what they are eating carefully and always to be prepared with an epinephrine autoinjector in case a reaction does occur.”
First Peanut Allergy Drug Approved by FDA for Kids
First treatment for peanut allergies is about to hit the market, a significant step toward better care for all kinds of food allergies. The US Food and Drug Administration (FDA) has approved the first drug known as Palforzia to treat peanut allergies in children and teens.
First treatment for peanut allergies is about to hit the market, a significant step toward better care for all kinds of food allergies. The US Food and Drug Administration (FDA) has approved the first drug known as Palforzia to treat peanut allergies in children and teens.
Source-Newswise
New Insights into Peanut Allergy Severity Discovered
Peanut allergy varies widely in severity and is the leading cause of fatal food-related anaphylaxis. Scientists have identified novel genes associated with the severity of peanut allergy, as well as ways in which these genes interact with other genes during allergic reactions.
Peanut allergy varies widely in severity and is the leading cause of fatal food-related anaphylaxis. Scientists have identified novel genes associated with the severity of peanut allergy, as well as ways in which these genes interact with other genes during allergic reactions.
Immunotherapy for Peanut Allergy Provides Protection but Not a Cure: Study
Researchers tested samples from patients who suffer from peanut allergy with peanut oral immunotherapy (POIT) and revealed that it does not stop them being allergic just suppresses the reaction.
Researchers tested samples from patients who suffer from peanut allergy with peanut oral immunotherapy (POIT) and revealed that it does not stop them being allergic just suppresses the reaction.
